Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 May;29(5):2754-2755.
doi: 10.1245/s10434-022-11423-5. Epub 2022 Feb 11.

A Colon Resection and Pump Implantation in the Same Surgical Procedure: Is it Safe?

Bas Groot Koerkamp  1 , Dirk J Grunhagen  2 , Cornelis Verhoef  2
Affiliations
Editorial

A Colon Resection and Pump Implantation in the Same Surgical Procedure: Is it Safe?

Bas Groot Koerkamp et al. Ann Surg Oncol. 2022 May.
No abstract available

PubMed Disclaimer

References

    1. Groot Koerkamp B, Sadot E, Kemeny NE, et al. Perioperative hepatic arterial infusion pump chemotherapy is associated with longer survival after resection of colorectal liver metastases: a propensity score analysis. J Clin Oncol. 2017;35(17):1938–44. - DOI
    1. Buisman FE, Homs MYV, Grunhagen DJ, et al. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases—the multicenter randomized controlled PUMP trial. BMC Cancer. 2019;19(1):327. - DOI
    1. Kemeny NE, Gonen M. Hepatic arterial infusion after liver resection. N Engl J Med. 2005;352(7):734–5. - DOI
    1. Kanemitsu Y, Shimizu Y, Mizusawa J, et al. Hepatectomy followed by mFOLFOX6 versus hepatectomy alone for liver-only metastatic colorectal cancer (JCOG0603): a Phase II or III randomized controlled trial. J Clin Oncol. 2021;39(34):3789–99. - DOI
    1. Nordlinger B, Sorbye H, Glimelius B, et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013;14(12):1208–15. - DOI

Publication types